Among the male patients with breast cancer, five of six who tested positive had a variant in CHEK2 or PALB2, both of which have been previously implicated in male breast cancer.35,36ATM accounted for 10.0% (33/330) of positive findings among female patients with breast cancer, making it a common finding. Here, PALB2 is linked to breast cancer.